Abstract
purpose. To increase the number of diabetic patients being screened for retinopathy, an instrument, the DigiScope, was specifically designed to operate in primary-care physicians’ offices. The DigiScope is described and its automated functions are evaluated.
methods. The DigiScope consists of a semiautomated optical head to acquire fundus images, evaluate visual acuity, and transmit the data to a remote reading center through telephone lines. Normal volunteers and 17 consecutive diabetic patients visiting their primary-care physician were recruited, and nonophthalmic staff performed the acquisition session.
results. The pupil center and working distance were set automatically. Centering was achieved within 750 μm in less than 500 ms. The fundus was successfully focused by an automated algorithm, and an imaging session covering 71° of the posterior pole of both eyes lasted 5.6 ± 2.4 minutes. It was found that a file-compression ratio of 12 did not degrade the clinical information and allowed data transfer in less than 6 minutes. A pilot study in normal eyes showed that the DigiScope images yielded the same amount of details as conventional color fundus photographs obtained by an expert photographer.
conclusions. The DigiScope fulfills the instrumental requirements for a practical and cost-effective tool to acquire data needed to identify diabetic patients who must be referred to an eye-care specialist. Widespread screening with the DigiScope may help reduce the risk of vision loss in an estimated 4 million individuals in the United States alone, who currently do not undergo an annual eye examination.
Diabetic retinopathy is estimated to be the most frequent cause of new cases of blindness among adults 20 to 60 years of age.
1 Prospective clinical trials have shown that panretinal laser photocoagulation for neovascular proliferation can reduce the risk of severe visual loss from proliferative retinopathy and that focal laser treatment for macular edema can reduce the risk of moderate visual loss.
1 The effectiveness of treatment depends on accurate and timely detection of retinopathy. Thus, to quote the Center for Disease Control’s Guideline for Primary Care Practitioners: “Because mild, moderate and even severe retinopathy may be present without any symptoms, the responsibility to screen or examine the patient with diabetes for retinopathy is significant” (Ref.
2 , p 45).
As stated by many experts, regular screening for diabetic retinopathy and education of patients are critical in limiting visual loss. Unfortunately, many diabetic patients do not receive an annual eye examination. A review of the literature by Mukamel et al.
3 indicates that, in the United States, less than half of the diabetic population receives an annual eye examination. Lack of awareness by the primary-care physician used to be considered an important factor, but even in health plans owned by well-informed physicians, the screening rate is low. Patient education has had a marginal effect, as indicated by the poor results despite efforts by managed-care plans to provide informational brochures. Cost is not the culprit, because health plans with no copayment have screening rates in the 40% to 50% range.
It has been suggested repeatedly that one promising approach to increasing screening could be based on the acquisition of fundus photographs at locations frequently visited by patients, followed by expert evaluation of the photographs.
4 5 6 7 8 9 10 11 12 Because diabetic patients visit their primary-care physicians often, screening in this setting would increase the screening rate significantly. However, the practical implementation of such a screening faces stringent demands:
-
A typical primary-care physician who cares for 2000 adults is likely to see, on average, 80 patients with diabetes (using a prevalence of 4%). A practice with four primary-care physicians would thus care for 320 diabetic patients and would screen, on average, approximately 1 patient a day. This low volume implies that the cost of the instrumentation used for screening must be low.
-
The procedure must be easy to administer by non–eye-care personnel, such as a physician’s assistant or a secretary.
-
The images must have enough resolution and contrast to allow the detection of small vascular abnormalities.
-
The imaged area must cover a significant portion of the posterior pole.
-
The data must be digital, to be compatible with transfer to a remote reading center.
None of the existing fundus cameras can meet all these demands. We have thus developed a fundus camera, referred to as the DigiScope, dedicated to detect, in the primary-care physician’s office, abnormalities that indicate the need for referral to an ophthalmologist familiar with the treatment of retinopathy. This article describes the DigiScope and the assessment of its automatic features. The application and performance in diabetic patients is the subject of another study lead by an independent investigator. Preliminary findings presented in abstract form showed a sensitivity of 0.99 and a specificity of 0.96.
13
Principle.
The DigiScope consists of an optical head located at the site of screening (typically the primary-care physician’s office) to acquire digital images and transmit them through phone lines to a remote reading center.
A panel of experts from the American College of Physicians, the American Diabetes Association, and the American Academy of Ophthalmology have stated in their screening guidelines for diabetes retinopathy: “Stereoscopic fundus photographs are the ‘gold standard’ for diagnosis. They provided the assessment for the Diabetic Retinopathy Study (DRS), the Early Treatment Diabetic Retinopathy Study (ETDRS) and the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR), and they measure the accuracy of [the] diagnostic approaches.”
14 A new imaging method for detecting diabetic retinopathy should provide the same diagnostic power as the current gold standard. Our pilot estimates, based on digitization of fundus photographs, indicated that a resolution of 50 pixels per degree would suffice. Although others have shown that good results can be obtained with less pixel density,
15 it is preferable to fulfill initially higher requirements and lower them if it can be shown that they do not lower the specificity and sensitivity significantly. Because the cost of the instrument is an important factor in determining its practical use in screening, we have chosen to use a low-cost video camera as the electronic imaging device. Such cameras typically yield images with 930 pixels diagonally. This implies that a field of 19° can be imaged. To provide coverage for the posterior pole, the instrument is designed to acquire multiple digital images at the required resolution in a manner that allows later generation of a mosaic image covering the posterior pole.
Another requirement for practical implementation is ease of operation by available staff in a primary-care environment. This implies that the instrument must operate quasiautomatically. To obtain a fundus image with refractive optics the operator must be able to align the center of the pupil with the optical axis of the camera, set the pupil at a well-defined working distance from the camera, focus the fundus image, adjust the light level, and image the correct region of the fundus.
These conditions must be met simultaneously in the short period during which a patient can comfortably fixate and keep the eyelids open. As will be described, the DigiScope has been designed to perform these functions without input from the operator.
The DigiScope uses monochromatic illumination. Treatable diabetic retinopathy is diagnosed by abnormalities associated with blood vessels. These are optimally visualized under illumination in red-free green light.
16 17 Imaging in monochromatic light yields other important advantages. It permits use of a black-and-white video camera (thereby reducing the cost and increasing resolution in comparison to color video cameras) and alleviates the need for careful correction of chromatic aberrations.
Macular edema is a complication of diabetic retinopathy that must be identified in a screening program. In previous studies, macular edema was assessed by reviewing stereophotographs of the fundus. However, with the introduction of objective methods to assess retinal thickening such as the retinal thickness analyzer (RTA) and optical coherence tomography (OCT), it has been recognized that stereophotography provides limited sensitivity.
18 The risk of missing macular edema will be limited by assessing visual acuity with the DigiScope and by referring any patients with early-stage retinopathy (a few microaneurysms or hemorrhages). In the WESDR cohort of 569 eyes of diabetic patients with disease classified as nonproliferative, none was found to have clinically significant macular edema (CSME).
19 Thus, there is very little risk, if at all, that CSME can be present without the presence of retinopathy that would trigger a referral. This issue has been addressed by the independent investigator who assessed screening with the DigiScope.
13
General Description of the DigiScope.
The image of the pupil captured by the video camera (10) appears as a disc darker than most of the surrounding iris, sclera, and lids. The image is processed by a software algorithm that first performs a dynamic threshold operation and converts the pupil into a black disc and the surrounding tissue into white. The image is inverted to generate a white disc for the pupil surrounded by black. The algorithm then locates the position of the pupil center along the horizontal and vertical axes.
The amount of deviation of the pupil center from the center of the image is used to command the X and Z stages and nullify this deviation. The procedure is repeated until the center of the pupil is close to the center of the image, thereby aligning the pupil with the optical axis of the imaging optics.
A first target is presented to the subject. Pupil tracking is initiated, and the optical head is aligned with the optical axis of the eye and positioned at the working distance. The fixation diode turns into a flickering mode to further attract the subject’s attention and, if the pupil is still centered, the fundus is imaged in the focusing mode. The best-focused image and the brightness of that image are determined. The imaging lens and the intensity of the bulb are set accordingly. This procedure is repeated for fine adjustment of focus and light intensity.
The imaging session then begins. The different targets corresponding to the different areas in the fundus are presented in sequence. For each desired location on the fundus, a single diode is turned on. For each location, the pupil is tracked and centered on the monitor. The fundus is imaged in one of the two modes according to a preset choice for each target. The digitized images are presented to the operator on the touch screen. The operator accepts the fundus images or repeats the acquisition, and accepted images are saved.
The role of the operator is limited to instructing the patient about the procedure, encouraging the patient to fixate well when the target light flickers, and checking the general quality of the images before saving them. To minimize further the role of the operator, computerized voice messages are implemented (potentially in various languages) to provide feedback and instructions to the patient and the operator.
A DigiScope was installed in an office with a number of primary-care physicians, and the staff was instructed in its use. The first 17 consecutive sessions were used for this study. Employees at the Wilmer Eye Institute volunteered to be imaged by the DigiScope and a conventional fundus camera. They were devoid of eye disease and signed an informed consent form. The recruitment was performed in accordance with the Declaration of Helsinki for research involving human subjects.
Before the imaging with the DigiScope, the eyes were dilated with 1% tropicamide ophthalmic solution and, if the pupil were less than 5 mm, 1% phenylephrine hydrochloride was instilled.
Pupil Alignment.
The time required to detect the pupil’s center was derived from the computer clock reading before and after the routine. The time required to finish the alignment sequence was determined for each subject by recording the computer clock.
The precision of the alignment was assessed by saving the pupil image obtained after the alignment before fine fundus focusing. The deviation from the intended location of the pupil’s center was assessed by the SD of the distance between the computed center of the pupil and the nominal location. This location was not necessarily the center of the screen, due to the introduction of an offset programmed for each target, to minimize corneal reflections.
Fundus Focusing.
Acquisition Time.
Compression Ratio.
Transfer Time.
Bresnick et al.,
21 in a recent article based on the ETDRS data, has shown that fundus photography can be used for screening of patients and has concluded that “if the protocols can be implemented effectively in a primary care setting, patients requiring referral for specialty care could be reliably identified.” Presently, the barrier to implementation in the primary-care setting is the cost of the equipment necessary to acquire and transfer digital images and the need for well-trained operators.
The DigiScope was developed to permit efficient and cost-effective implementation in the primary-care setting. As mentioned in the Methods section, the DigiScope had to satisfy a number of stringent demands to be of practical use.
The DigiScope was shown to have effective automated functions that alleviate the need for a trained photographer. The pupil alignment based on image processing of digital images was found to center the pupil within 700 μm in less than 270 ms. Because the mean pupil diameter was 5.5 mm, the precision is equivalent to 13% of the pupil diameter. This precision ensures that, when the image is taken, the optics of the eyes are well aligned with those of the DigiScope, thereby optimizing the optical quality and the illumination. On the rare occasions that the present algorithm fails because of partial eyelid closure or blink, the operator can proceed by pointing at the center of the pupil seen on the monitor. Based on reflections on the cornea, the DigiScope can automatically set the working distance. The procedure for focusing the fundus is efficient enough to ensure that the best-focused image is within the series of four images acquired at each location.
One of the requirements for the quality of the DigiScope image was that it must provide the same clinical information as the gold standard—namely, conventional fundus photography on film. To make this comparison, we chose a high-quality fundus camera operated by certified ophthalmic photographers. The pilot test in normal eyes indicated, as shown in
Figure 7 , that the smallest vascular features seen on the conventional photograph were also visible on the DigiScope image. The monochromatic imaging of the DigiScope seems to enhance the contrast and ease the visualization of white and red features. All diabetic retinopathy lesions fall into this category, particularly those that differentiate mild from more severe retinopathy: microaneurysms, exudates, and hemorrhages. The sensitivity and specificity of screening with the DigiScope needed evaluation, and an independent investigator has performed a validation study. The results, presented in part at the 2001 annual meeting of ARVO, showed a sensitivity of 0.99 and a specificity of 0.96.
13 The upcoming publication of the complete study will also provide information on the prevalence of images that are ungradable due to such factors as media opacity, high myopia, and pseudophakia.
The imaging procedure was acceptable to the subjects. They all found that the light’s intensity was much more comfortable than the flash in conventional photography. The light-energy density of the DigiScope is 1.1 mW/cm
2, or more than three orders of magnitude less than the recommended permissible exposure. Conventional-flash fundus cameras are typically one to two orders of magnitude below the recommended permissible exposure.
20
For the time being, the DigiScope will be used with drug-induced dilation to ensure good images in a large portion of the population. Dilation is not an added procedure, because the current preferred practice procedures call for a dilated eye examination, and photography with mydriasis has not been as successful as imaging without. Moreover, if dilation is performed with tropicamide, there is no risk of inducing angle closure, as demonstrated by the review of the literature between 1933 and 1999.
22 The staff in charge of dilation will be instructed on the symptoms of angle closure and on the steps to be taken. The drawback of mydriasis is the time necessary to achieve dilation, even the required 4- to 5-mm diameter. Therefore, means to image without pharmacologic dilation will be investigated.
Once the images have been acquired, they must be transferred to a reading center. We have chosen to use FTP through the Internet rather than e-mail, which may transfer different parts of the data via separate routes. We found that by compressing the data by a factor of 12, a whole session can be transferred through regular telephone lines in less than 10 minutes. This time is totally acceptable, because the automatic transfer is performed outside office hours, and a typical office is expected to screen an average of one patient a day. Our pilot tests have shown that this compression does not affect the informative content of the images.
In summary, this evaluation of the DigiScope indicates that it fulfills the requirements for a practical and cost-effective instrument for the acquisition of clinical data that could be used to identify diabetic patients who must be referred to an eye care specialist. Should validation studies in diabetic patients indicate that this screening method is sensitive and specific, its widespread use in the United States alone is likely to reduce the risk of vision loss in 8 million individuals, half of whom currently do not receive annual eye examinations.
Supported by EyeTel, Inc. Under an agreement between EyeTel and the Johns Hopkins University, RZ is entitled to a share of sales royalty received by the University from EyeTel. RZ and the university own EyeTel stock, which under university policy, cannot be traded until 2 years after the first sale of U.S. Food and Drug Administration–approved products related to the research described in this consent form. The terms of this agreement have been reviewed and approved by The Johns Hopkins University, in accordance with its conflict-of-interest policy.
Submitted for publication June 22, 2001; revised December 19, 2001; accepted January 8, 2002.
Commercial relationships policy: P, F (RZ); E, F (SZ, TM, KQ); N (SV).
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked “
advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Ran Zeimer, Johns Hopkins University School of Medicine, Wilmer Ophthalmological Institute, 600 N. Wolfe Street, Wilmer/Woods Building 355, Baltimore, MD 21287-9131;
[email protected].
The American Academy of Ophthalmology Quality of Care Committee Retina Panel. Diabetic Retinopathy. Preferred Practice Patterns. 1989; American Academy of Ophthalmology San Diego, CA.
National Center for Chronic Disease Prevention and Health Promotion of the Centers for Disease Control. The prevention and treatment of complications of diabetes. A Guide for Primary Care Practitioners. 1991;1–93. Centers for Disease Control Atlanta, GA.
Mukamel DB, Bresnick GH, Wang Q, Dickey CF. Barriers to compliance with screening guidelines for diabetic retinopathy. Ophthalmic Epidemiol
. 1999;6:61–72.
[CrossRef] [PubMed]Jacob J, Stead J, Sykes J, Taylor D, Tooke J. A report on the use of technician ophthalmoscopy combined with the use of the Canon non-mydriatic camera in screening for diabetic retinopathy in the community. Diabetic Med
. 1995;12:419–425.
[CrossRef] [PubMed]Cooney M, Schachat AP. Screening for diabetic retinopathy. Sanchez-Thorin J eds. International Ophthalmology Clinics. 1999;38:111–122. Lippincott-Raven Philadelphia.
Evans PMS, Purewal T, Hopper A, et al. Screening for diabetic retinopathy in primary care: retinal photography alone can be used efficiently and effectively to exclude those with sight threatening lesions. J Med Screen
. 1997;4:174–176.
[PubMed]Lee P. Telemedicine: opportunities and challenges for the remote care of diabetic retinopathy. Arch Ophthalmol
. 1999;117:1639–1640.
[CrossRef] [PubMed]Greenwood R. Population-based screening for diabetic retinopathy: a promising start. Diabet Med
. 1996;13:925–926.
[CrossRef] [PubMed]Li HK. Telemedicine and ophthalmology. Surv Ophthalmol
. 1999;44:61–72.
[CrossRef] [PubMed]Klein R. Barriers to prevention of vision loss caused by diabetic retinopathy. Arch Ophthalmol
. 1997;115:1073–1074.
[CrossRef] [PubMed]Taylor R. Practical community screening for diabetic retinopathy using the mobile retinal camera: report of a 12 centre study. Diabet Med
. 1996;13:946–952.
[CrossRef] [PubMed]Bursell SE, Cavallerano JD, Cavallerano AA, et al. Stereo nonmydriatic digital-video color retinal imaging compared with early treatment diabetic retinopathy study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology
. 2001;108:572–585.
[CrossRef] [PubMed]Schiffman RM, Jacobsen G, Nussbaum JJ, et al. The DigiScope compared with 7-field photography for the detection of diabetic retinopathy [ARVO Abstract]. Invest Ophthalmol Vis Sci. 2001;42(4)S741.Abstract nr 3968
American College of Physicians and American Academy of Ophthalmology. Screening guidelines for diabetic retinopathy. Ann Intern Med
. 1992;116:683–685.
[CrossRef] [PubMed]Aiello LM, Bursell SE, Cavallerano J, Gardner WK, Strong J. Joslin Vision Network Validation Study: pilot image stabilization phase. J Am Optom Assoc
. 1998;69:699–710.
[PubMed]Delori FC, Pflibsen KP. Spectral reflectance of the human ocular fundus. Appl Opt
. 1989;28:1061–1077.
[CrossRef] [PubMed]Delori FC, Gragoudas ES, Francisco R, Pruett RC. Monochromatic ophthalmoscopy and fundus photography: the normal fundus. Arch Ophthalmol
. 1977;95:861–868.
[CrossRef] [PubMed]Shahidi M, Ogura Y, Blair NP, Rusin M, Zeimer R. Retinal thickness analysis for quantitative assessment of diabetic macular edema. Arch Ophthalmol
. 1991;109:1115–1119.
[CrossRef] [PubMed]Klein R, Klein BEK, Moss SE. The Wisconsin epidemiologic study of diabetic retinopathy. IV: diabetic macular edema. Ophthalmology
. 1984;91:1464–1474.
[CrossRef] [PubMed]Delori FC, Parker JS, Mainster MA. Light levels in fundus photography and fluorescein angiography. Vision Res
. 1980;20:1099–1104.
[CrossRef] [PubMed]Bresnick GH, Mukamel DB, Dickinson JC, Cole DR. A screening approach to the surveillance of patients with diabetes for the presence of vision-threatening retinopathy. Ophthalmology
. 2000;107:19–24.
[CrossRef] [PubMed]Pandit RJ, Taylor R. Mydriasis and glaucoma: exploding the myth: a systematic review. Diabet Med
. 2000;17:693–699.
[CrossRef] [PubMed]